Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lerman, Sam
NCT06383390: The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES)	Recruiting	3	10000	Europe, Canada, US, RoW	Retatrutide, LY3437943, Placebo	Eli Lilly and Company	Overweight and Obesity	02/29	02/29
QWINT-5, NCT05463744: A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy	Completed	3	692	Europe, Japan, US, RoW	Insulin Efsitora Alfa, LY3209590 and Basal Insulin-FC, Insulin Degludec	Eli Lilly and Company	Type 1 Diabetes, Diabetes	05/24	05/24
VICTORION-1 PREVENT, NCT05739383: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.	Recruiting	3	14000	Europe, Canada, US, RoW	Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, KJX839, Placebo in 1.5ml	Novartis Pharmaceuticals	Primary Prevention of Atherosclerotic Cardiovascular Disease	04/29	04/29
NA-PAS, NCT04836546: Eversense® Non-adjunctive Use Post Approval Study	Recruiting	N/A	925	US	Blood glucose meter, Eversense CGM System	Senseonics, Inc.	Diabetes	03/26	03/26
Elkadry, Ayman
NA-PAS, NCT04836546: Eversense® Non-adjunctive Use Post Approval Study	Recruiting	N/A	925	US	Blood glucose meter, Eversense CGM System	Senseonics, Inc.	Diabetes	03/26	03/26
Ghamlouche, Ahmad
NA-PAS, NCT04836546: Eversense® Non-adjunctive Use Post Approval Study	Recruiting	N/A	925	US	Blood glucose meter, Eversense CGM System	Senseonics, Inc.	Diabetes	03/26	03/26